Revenue: The sum of all revenue fields included for a company's operating activities.
Cellectar Biosciences, Inc. (CLRB) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-6.93M |
|
-- |
|
-- |
|
$7.20M |
|
$-7.20M |
|
$0.27M |
|
$-6.93M |
|
$-7.06M |
|
$-6.93M |
|
$-6.93M |
|
$-6.93M |
|
$-7.06M |
|
$-7.20M |
|
$-7.16M |
|
12.23M |
|
12.23M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$34.88M |
|
$0.30M |
|
$1.76M |
|
$36.64M |
|
$5.24M |
|
-- |
|
$1.53M |
|
$6.77M |
|
$29.87M |
|
$29.87M |
|
$29.87M |
|
8.25M |
|
| Cash Flow Statement Financials | |
$-10.86M |
|
$-0.00M |
|
$31.66M |
|
$13.20M |
|
$33.99M |
|
$20.80M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.20% |
|
-23.20% |
|
-18.92% |
|
-23.20% |
|
$3.62 |
|
$-0.89 |
|
$-0.89 |
|